丙氧基硫代高昔多芬 | 479073-88-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 丙氧基硫代高昔多芬
• 英文名称: Propoxyphenyl thiohomosildenafil
• 英文别名: 5-[5-(4-ethylpiperazin-1-yl)sulfonyl-2-propoxyphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidine-7-thione
• CAS: 479073-88-6
• 化学式: C₂₄H₃₄N₆O₃S₂
• 分子量: 518.7
• InChiKey: NOAOIWRANOXNDE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  35
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  133
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• Novel pyrazolopyrimidinethione derivatives, preparation methods thereof and their use as therapeutics for erectile dysfunction
  申请人：——

  公开号：US20040176371A1

  公开（公告）日：2004-09-09

  Novel pyrazolopyrimidinethione compounds of formula 1: wherein R 1 and R 2 are independently each hydrogen atom, a C 1 -C 6 alkyl group, or a C 3 -C 6 cycloalkyl group, R 3 is a C 1 -C 6 alkyl group. C 3 -C 6 cycloalkyl group or C 3 -C 6 alkenyl group which is substituted or unsubstituted, X is O or NR 4 , and R 4 is hydrogen atom, or a C 1 -C 6 alkyl group, a C 3 -C 6 cycloalkyl group or a C 3 -C 6 alkenyl group which is unsubstituted or substituted with OH or an alkoxy group, pharmacologically acceptable salts or hydrates thereof, and preparation methods thereof are disclosed. Pharmaceutical compositions comprising the compounds are effectively used for the treatment of erectile dysfunction.

  化合物1的新型吡唑并嘧啶硫酮化合物，其中R1和R2分别独立地为氢原子、C1-C6烷基或C3-C6环烷基，R3为C1-C6烷基、C3-C6环烷基或C3-C6烯基，可以是取代或未取代的，X为O或NR4，而R4为氢原子或C1-C6烷基、C3-C6环烷基或C3-C6烯基，可以是未取代或取代的，其中取代基为OH或烷氧基，其药物学上可接受的盐或水合物以及其制备方法被披露。包含这些化合物的制药组合物可有效用于治疗勃起功能障碍。
• NOVEL PYRAZOLOPYRIMIDINETHIONE DERIVATIVES. PREPARATION METHODS THEREOF AND THEIR USE AS THERAPEUTICS FOR ERECTILE DYSFUNCTION
  申请人：Korea Institute of Science and Technology

  公开号：EP1395593A1

  公开（公告）日：2004-03-10
• EP1395593A4
  申请人：——

  公开号：EP1395593A4

  公开（公告）日：2004-11-10
• [EN] NOVEL PYRAZOLOPYRIMIDINETHIONE DERIVATIVES. PREPARATION METHODS THEREOF AND THEIR USE AS THERAPEUTICS FOR ERECTILE DYSFUNCTION<br/>[FR] NOUVEAUX DERIVES DE PYRAZOLOPYRIMIDINETHIONE, PROCEDES DE PREPARATION DE CEUX-CI ET UTILISATION COMME AGENTS THERAPEUTIQUES POUR LES DYSFONCTIONNEMENTS DE L'ERECTION
  申请人：KOREA INST SCI & TECH

  公开号：WO2002102802A1

  公开（公告）日：2002-12-27

  Novel pyrazolopyrimidinethione compounds of formula 1: wherein R1 and R2 are independently each hydrogen atom, a C1-C6 alkyl group, or a C3-C6 cycloalkyl group, R3 is a C1-C6 alkyl group, C3-C6 cycloalkyl group or C3-C6 alkenyl group which is substituted or unsubstituted, X is O or NR4, and R4 is hydrogen atom, or a C1-C6 alkyl group, a C3-C6 cycloalkyl group or a C3-C6 alkenyl group which is unsubstituted or substituted with OH or an alkoxy group, pharmacologically acceptable salts or hydrates thereof, and preparation methods thereof are disclosed. Pharmaceutical compositions comprising the compounds are effectively used for the treatment of erectile dysfunction.